PCPhilippe Cinquin

Philippe Cinquin

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Philippe Cinquin has a total of 67 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    The vascular connector, design of a new device for sutureless vascular anastomosis

    by Lulzim Vokrri, Xhavit Krasniqi, Arsim Qavdarbasha, Nexhmi Hyseni, Philippe Cinquin, Paolo Porcu, Carmine Sessa

    In recent years, several methods and new techniques have been studied and proposed for establishment of sutureless vascular anastomoses, streaming use of sutureless vascular surgery in the future. The new vascular connector (NVC) is a hypothetical design of a vascular device, proposed for creation and maintenance of sutureless vascular anastomosis. Implication of NVC would introduce a new device and technique in establishment of sutureless vascular anastomosis in which surgical approach is minimized and so post-operation disorders. It would eliminate need for suture; shorten clampage and operation time, consequently reducing stress for both, the surgeon and the patient. It enables the creation of vascular anastomosis fast, simple, safe, reliable, with satisfactory patency and stability of anastomosis. Efficacy of NVC needs to be evaluated in further studies, in order to be confirmed for clinical use. The effectiveness of NVC should be verified firstly in vitro and in vivo tests; and by animal experiments. The likelihood of its negative influence in thrombogenicity should be well evaluated. Implication of the new vascular connector (NVC) would be of interest to both patients and the surgeon due to the following main achievements: 1) enables the creation of vascular anastomosis fast and simple, 2) significant shortening of clampage time of blood vessels and operation time-this assumption would be followed by reduced risk of operative and post-operative complications and length of hospital stay or admission to Intensive care unit, 3) safe and reliable, 4) compatible with any blood vessel and standard vascular graft, 5) using the NVC we will reduce in minimum need for replaced blood volume, 6) reduces the cost of treatment. It is anticipated that the NVC would provide shorter operation time and least operative and post-operative complications in creation of sutureless vascular anastomosis.


  • Multi-view vision system for laparoscopy surgery

    by Brahim Tamadazte, Anthony Agustinos, Philippe Cinquin, Gaelle Fiard, Sandrine Voros

    A global endoscopic view of the surgical field could help avoid complications such as perforation of occluded organs and may reduce the endoscope displacements and also the usual time of laparoscopic procedure using a conventional endoscopy system. An augmented laparoscopy system was developed by increasing the field of view of a traditional endoscope. This system was implemented and tested in vitro using a testbench. High-definition miniature cameras were integrated into a traditional endoscope to obtain a panoramic vision device with a large field of view of the abdominal cavity. The additional cameras are mounted around the endoscopy body as a pair of glasses providing a global view of the abdominal cavity completing the traditional endoscopic view. Each camera can reach a frame rate of 30 images/second with a resolution of 1,600 \(\times \) 1,200 pixels. To be able to fix the cameras to the endoscope, a deployment, fixation and rapid extraction system of the proposed device through the trocar was designed and validated in preclinical experiments (testbench and human cadaver). The preclinical experiments compared the time required to perform a pick-and-place task with the traditional endoscope alone and with the proposed system alone. A statistically significant reduction in procedure time was found using an augmented video endoscopy system for a pick-and-place task. An augmented laparoscopy system with increased field of view is feasible and may be advantageous compared with a traditional endoscope. In vivo testing of the system should be done to establish the clinical utility of this innovation.


  • Open Access

    Implantable Glucose BioFuel Cells for Medical Devices

    by P Cinquin, S Cosnier, N Belgacem, M L Cosnier, R Dal Molin, D K Martin

    An Implantable BioFuel Cell (IBFC) is a device that produces power only from the chemicals that are naturally occurring inside the body. We have been working on two approaches to creating an IBFC. The first approach is to use chemicals such as glucose and oxygen to provide the fuel for an enzymatic IBFC. The second approach is to use electrolytes such as sodium to provide the fuel for a biomimetic IBFC.


  • Top Cited Papers
    Open Access

    Single Glucose Biofuel Cells Implanted in Rats Power Electronic Devices

    by A. Zebda, S. Cosnier, J.-P. Alcaraz, M. Holzinger, A. Le Goff, C. Gondran, F. Boucher, F. Giroud, K. Gorgy, H. Lamraoui, et al.

    We describe the first implanted glucose biofuel cell (GBFC) that is capable of generating sufficient power from a mammal's body fluids to act as the sole power source for electronic devices. This GBFC is based on carbon nanotube/enzyme electrodes, which utilize glucose oxidase for glucose oxidation and laccase for dioxygen reduction. The GBFC, implanted in the abdominal cavity of a rat, produces an average open-circuit voltage of 0.57 V. This implanted GBFC delivered a power output of 38.7 μW, which corresponded to a power density of 193.5 μW cm−2 and a volumetric power of 161 μW mL−1. We demonstrate that one single implanted enzymatic GBFC can power a light-emitting diode (LED), or a digital thermometer. In addition, no signs of rejection or inflammation were observed after 110 days implantation in the rat.


  • A quinhydrone biofuel cell based on an enzyme-induced pH gradient

    by Fabien Giroud, Chantal Gondran, Karine Gorgy, Aymeric Pellissier, François Lenouvel, Philippe Cinquin, Serge Cosnier


  • Top Cited Papers
    Open Access

    A Glucose BioFuel Cell Implanted in Rats

    by Philippe Cinquin, Chantal Gondran, Fabien Giroud, Simon Mazabrard, Aymeric Pellissier, François Boucher, Jean-Pierre Alcaraz, Karine Gorgy, François Lenouvel, Stéphane Mathé, et al.

    Powering future generations of implanted medical devices will require cumbersome transcutaneous energy transfer or harvesting energy from the human body. No functional solution that harvests power from the body is currently available, despite attempts to use the Seebeck thermoelectric effect, vibrations or body movements. Glucose fuel cells appear more promising, since they produce electrical energy from glucose and dioxygen, two substrates present in physiological fluids. The most powerful ones, Glucose BioFuel Cells (GBFCs), are based on enzymes electrically wired by redox mediators. However, GBFCs cannot be implanted in animals, mainly because the enzymes they rely on either require low pH or are inhibited by chloride or urate anions, present in the Extra Cellular Fluid (ECF). Here we present the first functional implantable GBFC, working in the retroperitoneal space of freely moving rats. The breakthrough relies on the design of a new family of GBFCs, characterized by an innovative and simple mechanical confinement of various enzymes and redox mediators: enzymes are no longer covalently bound to the surface of the electron collectors, which enables use of a wide variety of enzymes and redox mediators, augments the quantity of active enzymes, and simplifies GBFC construction. Our most efficient GBFC was based on composite graphite discs containing glucose oxidase and ubiquinone at the anode, polyphenol oxidase (PPO) and quinone at the cathode. PPO reduces dioxygen into water, at pH 7 and in the presence of chloride ions and urates at physiological concentrations. This GBFC, with electrodes of 0.133 mL, produced a peak specific power of 24.4 µW mL−1, which is better than pacemakers' requirements and paves the way for the development of a new generation of implantable artificial organs, covering a wide range of medical applications.


  • Open Access

    TER: A Robot for Remote Ultrasonic Examination: Experimental Evaluations

    by Jean-Jacques Banihachemi, Eric Boidard, Jean-Luc Bosson, Luc Bressollette, Ivan Bricault, Philippe Cinquin, Gilbert Ferretti, Maud Marchal, Thomas Martinelli, Alexandre Moreau-Gaudry, et al.

    This chapter: o Motivates the clinical use of robotic tele-echography o Introduces the TER system o Describes technical and clinical evaluations performed with TER

  • Automatic Detection of Instruments in Laparoscopic Images: A First Step Towards High-level Command of Robotic Endoscopic Holders

    by Sandrine Voros, Jean-Alexandre Long, Philippe Cinquin

    The tracking of surgical instruments o fers interesting possibilities for the development of high-level commands for robotic camera holders in laparoscopic surgery. We have developed a new method to detect instruments in laparoscopic images which uses information on the 3D position of the insertion point of an instrument into the abdominal cavity. This information strongly constrains the search for the instrument in each endoscopic image. Hence, the instrument can be detected in near real-time using shape considerations. Early results on laparoscopic images show that the method is rapid and robust in the presence of partial occlusion and smoke. Our first experiment on a cadaver validates our approach and shows encouraging results.